MPM Capital

edit

Unique to MPM is an internal team of industry experts that has been specifically assembled not only to enable MPM to assess opportunities but to participate in the value creation and value enhancing acitivites once MPM is an investor. They believe that there senior team is the broadest and deepest team in healthcare venture capital, comprised of talented individuals with impressive investing and finance pedigrees, as well as persons who possess specific functional and operating expertise. MPM executives have and will continue to take interim operating positions in portfolio companies. They can “drop in” expertises in chemistry or biology, intellectual property, licensing and business development, clinical trial design and execution, and commercial operations. Whether we are helping build a company, filling in short-term management gaps, or working alongside management to prepare for key value-creating events, they do whatever it takes to help there companies succeed.

Milestones

edit

• 
  MPM Capital invested in PrimeraDx. (10/30/09)
  Posted 10/30/09 at 5:51pm
• 
  MPM Capital invested in Epizyme. (10/7/09)
  Posted 10/7/09 at 2:46pm
• 
  MPM Capital invested in PharmAthene. (7/27/09)
  Posted 9/28/09 at 2:44am
• 
  MPM Capital invested in iPierian. (7/8/09)
  Posted 9/28/09 at 2:14am
• 
  MPM Capital invested in Xanodyne. (6/23/09)
  Posted 6/23/09 at 10:21am
• 
  MPM Capital invested in Elixir Pharmaceuticals. (5/27/09)
  Posted 6/17/09 at 1:38pm
• 
  MPM Capital invested in Taigen. (1/09)
  Posted 5/20/09 at 12:03pm
• 
  MPM Capital invested in KaloBios Pharmaceuticals. (12/22/08)
  Posted 6/14/09 at 11:02pm
• 
  MPM Capital invested in ARYx Therapeutics. (11/12/08)
  Posted 7/14/09 at 9:53pm
• 
  MPM Capital invested in Innovative Spinal Technologies. (9/8/08)
  Posted 6/13/09 at 7:02am
• 
  MPM Capital invested in TriVascular2. (3/31/08)
  Posted 9/24/09 at 3:09am
• 
  MPM Capital invested in NeoVista. (12/8/06)
  Posted 9/17/09 at 2:01am
• 
  MPM Capital invested in Elixir Pharmaceuticals. (11/29/06)
  Posted 6/19/09 at 10:13am

Investments

Videos

Sources

1. MPM Capital raises $550M healthcare fund (venturebeat.com) [edit]
2. PrimeraDx, Inc.: Series C $20M (onbiovc.com) [edit]
3. Epizyme pulls in $32M in VC capital, new investors (fiercebiotech.com) [edit]
4. PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants (ir.pharmathene.com) [edit]
5. iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming (biocetera.com) [edit]
6. Xanodyne Pharmaceuticals, Inc.: Series D $38M (onbiovc.com) [edit]
7. Elixir Pharmaceuticals, Inc.: Series D $12M (onbiovc.com) [edit]
8. TaiGen Biotechnology Secures 37 Million USD in Series C Round Financing (reuters.com) [edit]
9. KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million (kalobios.com) [edit]
10. ARYx Therapeutics Inc. Announces $21.6 Million Private Placement (investors.aryx.com) [edit]
11. Innovative Spinal Technologies Jilted, Now Bankrupt, Source Says (xconomy.com) [edit]
12. Boston Scientific spinout TriVascular2 takes in $65M (deals.venturebeat.com) [edit]
13. NeoVista, a co. targeting age-related macular degeneration, raises $41M (deals.venturebeat.com) [edit]
14. Elixir raises $46M for fountain of youth (deals.venturebeat.com) [edit]